https://www.selleckchem.com/pr....oducts/atglistatin.h
The AUC of the model was 0.846 (95% CI, 0.790-0.902) for the training cohort and 0.733 (95% CI, 0.613-0.852) for the validation cohort. The calibration curves showed good agreement between the predictions and observations. Our novel nomogram demonstrates high accuracy in predicting ALN tumor burden in breast cancer patients. We also suggest further development of PyRadiomics to improve US radiomics. • A nomogram based on US was developed to predict ALN tumor burden (low, 3 metastatic ALNs; high, ≥ 3 metastatic ALNs). • The nomo
Beğen
Yorum Yap
Paylaş
